Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation

被引:12
作者
Dehnes, Yvette [1 ,3 ]
Shan, Jufang [4 ]
Beuming, Thijs [4 ,5 ]
Shi, Lei [4 ,6 ]
Weinstein, Harel [4 ,6 ]
Javitch, Jonathan A. [1 ,2 ,7 ]
机构
[1] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Pharmacol & Psychiat, New York, NY 10032 USA
[3] Univ Oslo, Inst Basic Med Sci, Ctr Mol Biol & Neurosci, Dept Anat, N-0317 Oslo, Norway
[4] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA
[5] Schrodinger Inc, New York, NY 10036 USA
[6] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA
[7] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
Dopamine transporter (DAT); Cocaine binding; Dopamine transport; Cysteine accessibility; Molecular dynamics simulations; NEUROTRANSMITTER-SODIUM SYMPORTER; SEROTONIN TRANSPORTER; SUBSTRATE TRANSLOCATION; COMPETITIVE INHIBITOR; TRANSMEMBRANE DOMAIN; BACTERIAL HOMOLOG; LEUT; MECHANISM; SITE; IDENTIFICATION;
D O I
10.1016/j.neuint.2014.02.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dopamine transporter (DAT), a member of the neurotransmitter:sodium symporter family, mediates the reuptake of dopamine at the synaptic cleft. DAT is the primary target for psychostimulants such as cocaine and amphetamine. We previously demonstrated that cocaine binding and dopamine transport alter the accessibility of Cys342 in the third intracellular loop (IL3). To study the conformational changes associated with the functional mechanism of the transporter, we made cysteine substitution mutants, one at a time, from Phe332 to Ser351 in IL3 of the background DAT construct, X7C, in which 7 endogenous cysteines were mutated. The accessibility of the 20 engineered cysteines to polar charged sulfhydryl reagents was studied in the absence and presence of cocaine or dopamine. Of the 11 positions that reacted with methanethiosulfonate ethyl ammonium, as evidenced by inhibition of ligand binding, 5 were protected against this inhibition by cocaine and dopamine (S333C, S334C, N336C, M342C and T349C), indicating that reagent accessibility is affected by conformational changes associated with inhibitor and substrate binding. In some of the cysteine mutants, transport activity is disrupted, but can be rescued by the presence of zinc, most likely because the distribution between inward- and outward-facing conformations is restored by zinc binding. The experimental data were interpreted in the context of molecular models of DAT in both the inward- and outward-facing conformations. Differences in the solvent accessible surface area for individual 113 residues calculated for these states correlate well with the experimental accessibility data, and suggest that protection by ligand binding results from the stabilization of the outward-facing configuration. Changes in the residue interaction networks observed from the molecular dynamics simulations also revealed the critical roles of several positions during the conformational transitions. We conclude that the 113 region of DAT undergoes significant conformational changes in transitions necessary for both cocaine binding and substrate transport. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4 / 15
页数:12
相关论文
共 51 条
[1]   Neurotransmitter transporters as molecular targets for addictive drugs [J].
Amara, SG ;
Sonders, MS .
DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (1-2) :87-96
[2]   The binding sites for cocaine and dopamine in the dopamine transporter overlap [J].
Beuming, Thijs ;
Kniazeff, Julie ;
Bergmann, Marianne L. ;
Shi, Lei ;
Gracia, Luis ;
Raniszewska, Klaudia ;
Newman, Amy Hauck ;
Javitch, Jonathan A. ;
Weinstein, Harel ;
Gether, Ulrik ;
Loland, Claus J. .
NATURE NEUROSCIENCE, 2008, 11 (07) :780-789
[3]   A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function [J].
Beuming, Thijs ;
Shi, Lei ;
Javitch, Jonathan A. ;
Weinstein, Harel .
MOLECULAR PHARMACOLOGY, 2006, 70 (05) :1630-1642
[4]   Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation [J].
Celik, Leyla ;
Sinning, Steffen ;
Severinsen, Kasper ;
Hansen, Carsten G. ;
Moller, Maria S. ;
Bols, Mikael ;
Wiborg, Ove ;
Schiott, Birgit .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (12) :3853-3865
[5]   The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding [J].
Chen, JG ;
Sachpatzidis, A ;
Rudnick, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28321-28327
[6]   Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine binding [J].
Chen, NH ;
Rickey, J ;
Berfield, JL ;
Reith, MEA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (07) :5508-5519
[7]  
Chen NH, 1998, J NEUROSCI, V18, P10257
[8]   Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter [J].
Chen, NH ;
Ferrer, JV ;
Javitch, JA ;
Justice, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :1608-1614
[9]   Coupled Global and Local Changes Direct Substrate Translocation by Neurotransmitter-Sodium Symporter Ortholog LeuT [J].
Cheng, Mary Hongying ;
Bahar, Ivet .
BIOPHYSICAL JOURNAL, 2013, 105 (03) :630-639
[10]  
Eshleman AJ, 1997, J NEUROCHEM, V69, P1459